Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). - Antoni, CE; Kavanaugh, A; van der Heijde, D (J Rheumatol, 2008)
et al.